Headache Impact Test (HIT-6)
Posted on July 31 2023,
HIT-6 is a reliable and valid tool for discriminating headache impact across episodic and chronic migraine. It was designed to provide a global measure of adverse headache impact and was developed to use in screening and monitoring patients with headaches in both clinical practice and clinical research.
The four headache impact severity categories are little or no impact (49 or less), some impact (50–55), substantial impact (56–59), and severe impact (60–78).
Reference: Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6TM) across episodic and chronic migraine. Cephalalgia. 2011;31(3):357-367. doi:10.1177/0333102410379890.
Candesartan for Migraine Prevention: What New Research Shows
New 2026 research shows candesartan, a low-cost blood pressure pill, can prevent migraines. Here is what the evidence says about how ARBs work, dosing, safety, and who should consider them.
Read MoreFri, May 08, 26
Does the Side of Your Migraine Actually Matter?
If you've been told your migraine attacks are damaging your brain or that the side they're on predicts anxiety or PTSD, the evidence doesn't support it.
Read MoreMigraine, Menopause, and Hormonal Health
Migraine affects women three times more than men, and menopause does not always bring relief. Nearly half of women continue having migraine attacks after menopause. Learn what the research says...
Read More
